TFX - TELEFLEX INC （）

Teleflex Incorporated found using ticker (TFX) have now 13 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 330 and 215 with the average target price sitting at 250.77. Now with the previous closing price of 225.71 this would imply there is a potential upside of 11.1%. The day 50 moving average is 207.33 and the 200 moving average now moves to 266.01. The market capitalisation for the company is $10,579m. Find out more information at: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $11,754m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” third-quarter 2022 investor letter – a copy of which can be downloaded here. The ClearBridge Mid Cap Growth Strategy underperformed the Russell Midcap Growth Index during the third quarter. On an absolute basis, the Strategy had losses across eight of the 10 sectors […]

WAYNE, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list.

According to Market Study Report, Medical Corrugated Tubing Market provides a comprehensive analysis of the Medical Corrugated Tubing Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in

WAYNE, Pa., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34 th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET).

Teleflex Incorporated with ticker code (TFX) now have 10 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 430 and 295 calculating the mean target price we have 352.8. Given that the stocks previous close was at 245.85 this would indicate that there is a potential upside of 43.5%. There is a 50 day moving average of 277.75 and the 200 day MA is 323.71. The company has a market cap of $11,964m. You can visit the company''s website by visiting: https://www.teleflex.com [stock_market_widget type="chart" template="basic" color="green" assets="TFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,168m based on the market concensus. Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Stocks that traded heavily or had substantial price changes Friday: Micron, Kohl’s fall; NextEra, Teleflex rise

Teleflex (TFX) said results from several research studies showed the safety and efficacy of its product, UroLift System, to treat men with enlarged prostate. The company said…

Presentations at the 37th Annual European Association of Urology Congress to Demonstrate Measurable and Sustained Improvement of BPH Symptoms and IPSS Scores WAYNE, Pa., July 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the results of several research studies that further support the safety and efficacy of the

Teleflex Incorporated (NYSE:TFX) shares, rose in value on Friday, 06/24/22, with the stock price up by 2.61% to the previous day’s close as strong demand from buyers drove the stock to $258.05. Actively observing the price movement in the last trading, the stock closed the session at $251.49, falling within a range of $250.37 and … Things To Consider Before Buying Teleflex Incorporated (NYSE: TFX) Read More »

Global Intra-Aortic Balloon Pump (IABP) Market report gives inside and out analysis of parent market patterns, large scale financial pointers and controlling aspects alongside market appeal according to sections. The report additionally maps the characteristic outcome of diverse market aspects

The comprehensive research report provides genuine information of the Global Mucosal Atomization Devices Market. Its scope study expands from market situation to comparative pricing among the major players, expense of the specific market areas and profits. It represents a comprehensive

The Global Custom Procedure Kits Market Report is a study of prevailing drivers, trends, forecast, and restraints in the global landscape. The report is the latest addition to the vast data repository of Research N Reports known for their original,

The latest Single Use Manual Resuscitators market study offers an all-inclusive analysis of the major strategies, corporate models, and market shares of the most noticeable players in this market. The study offers a thorough analysis of the key persuading factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. Request a []

Suprapubic Catheter market research helps to become more efficient and thereby get closer to your customers. It is a cost-effective method wherein there is no need to hire an expensive firm to start off. It helps one in the competitive